LAB vs MTCH · rev $174.4M vs P/E 13, rev $3.48B
Standard Biotools Inc (LAB) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
LAB currently screens at market cap $317.1M. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the LAB and MTCH stock pages for the full models.
Not investment advice.